Literature DB >> 3689031

Usage of community-based chloroquine treatment for malaria in Saradidi, Kenya.

D C Kaseje1, H C Spencer, E K Sempebwa.   

Abstract

A survey was done in June 1983 in Saradidi, Kenya, one year after the inception of a community-based malaria control programme to determine if people were obtaining malaria treatment from volunteer village health helpers (VHH's) chosen by the community. Ten of 36 villages were randomly chosen. From these ten villages, 100 households were randomly selected and 222 people ten years of age or more were interviewed; 113 (50.9%) had a history of malaria in the previous two weeks and 82 (72.6% of 113) had taken medicine for malaria in that period. Of these 82, 51.2% obtained drug from the VHH, 28% purchased it from a shop, 12.2% from a health facility, 4.9% from family members and 3.7% from a private practitioner or a shop outside Saradidi. Reasons given for not obtaining treatment from the VHH's among the 40 people who went elsewhere for treatment included: the VHH was not at home when needed (35%); the VHH had no drugs (22.5%); the patient was too sick for the VHH to treat (10%); had drugs already in the home (10%); 'not registered' with VHH (10%); VHH 'no good' (7.5%); and more 'convenient' to go elsewhere (5%). Similar results found on questioning the mother were obtained for 103 children under nine years old in these households; 67 (65.0%) children had a history of malaria in the previous two weeks and 59 (88.1%) of these 67 children had received antimalarial treatment. The VHH was the principal source of treatment (50.8% of 59), followed by health facilities (20.3%) and shops (18.6%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3689031     DOI: 10.1080/00034983.1987.11812196

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  7 in total

Review 1.  Medicine sellers and malaria treatment in sub-Saharan Africa: what do they do and how can their practice be improved?

Authors:  Catherine Goodman; William Brieger; Alasdair Unwin; Anne Mills; Sylvia Meek; George Greer
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

2.  Self-treatment of malaria in a rural area of western Kenya.

Authors:  T K Ruebush; M K Kern; C C Campbell; A J Oloo
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

3.  Econometric analysis to evaluate the effect of community-based health insurance on reducing informal self-care in Burkina Faso.

Authors:  Paul Jacob Robyn; Allan Hill; Yuanli Liu; Aurélia Souares; Germain Savadogo; Ali Sié; Rainer Sauerborn
Journal:  Health Policy Plan       Date:  2011-03-16       Impact factor: 3.344

Review 4.  Reviewing the literature on access to prompt and effective malaria treatment in Kenya: implications for meeting the Abuja targets.

Authors:  Jane Chuma; Timothy Abuya; Dorothy Memusi; Elizabeth Juma; Willis Akhwale; Janet Ntwiga; Andrew Nyandigisi; Gladys Tetteh; Rima Shretta; Abdinasir Amin
Journal:  Malar J       Date:  2009-10-28       Impact factor: 2.979

5.  Does enrollment status in community-based insurance lead to poorer quality of care? Evidence from Burkina Faso.

Authors:  Paul Jacob Robyn; Till Bärnighausen; Aurélia Souares; Germain Savadogo; Brice Bicaba; Ali Sié; Rainer Sauerborn
Journal:  Int J Equity Health       Date:  2013-05-16

6.  Improving ability to identify malaria and correctly use chloroquine in children at household level in Nakonde District, Northern Province of Zambia.

Authors:  Frederick AD Kaona; Mary Tuba
Journal:  Malar J       Date:  2003-11-19       Impact factor: 2.979

7.  Motivation of Community Health Workers in Diagnosing, Treating, and Referring Sick Young Children in a Multicountry Study.

Authors:  Armande K Sanou; Ayodele S Jegede; Jesca Nsungwa-Sabiiti; Mohamadou Siribié; IkeOluwapo O Ajayi; Asaf Turinde; Frederick O Oshiname; Luc Sermé; Vanessa Kabarungi; Catherine O Falade; Josephine Kyaligonza; Chinenye Afonne; Andrew Balyeku; Joëlle Castellani; Melba Gomes
Journal:  Clin Infect Dis       Date:  2016-12-15       Impact factor: 9.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.